1. Publications
McKay KA, Tremlett H, Patten SB, Fisk JD, Evans C, Fiest K, Campbell T, Marrie RA; CIHR
Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-
Canada prospective study. Mult Scler. 2016 Jun 29.
Zhang T, Tremlett H, Leung S, Zhu F, Kingwell E, Fisk JD, Bhan V, Campbell TL, Stadnyk K,
Yu BN, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple
Sclerosis. Examining the effects of comorbidities on disease-modifying therapy use in multiple
sclerosis. Neurology. 2016 Mar 4.
Kowalec K, Kingwell E, Yoshida EM, Marrie RA, Kremenchutzky M, Campbell TL, Wadelius
M, Carleton B, Tremlett H. Characteristics associated with drug-induced liver injury from
interferon beta in multiple sclerosis patients. Expert Opin Drug Saf. 2014 Oct;13(10):1305-17.
doi: 10.1517/14740338.2014.947958. Epub 2014 Aug 18.
Wong, S., Migounov, V., Campbell, TL., Morreale, M., Cass, E. Avonex PEN Satisfaction and
Patients Experience Clinical Trial. Canadian Journal of Neurological Sciences. November, 2013
40(6); 898-99.
Campbell, T Combining Physical Therapy with Dalfampridine in Patients with Multiple
Sclerosis and Walking Limitations, Consortium of Multiple Sclerosis Centers Newsletter Issue 1,
Orlando, Florida, USA, May 2013 – REVIEW ARTICLE
Campbell, T Prospective, Longitudinal Study of Natalizumab Treatment in MS Patients,
Consortium or Multiple Sclerosis Centers Newsletter Issue 2, Orlando, Florida, USA, May 2013
– REVIEW ARTICLE.
Campbell,T. Tysabri Patient Management Recommendations, Canadian Nursing Academy in
Multiple Sclerosis, April 2013
Disanto G1, Magalhaes S, Handel AE, Morrison KM, Sadovnick AD, Ebers GC, Banwell B, Bar-
Or A; Canadian Pediatric Demyelinating Disease Network (including Campbell, TL). HLA-
DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.
Neurology. 2011 Mar 1;76(9):781-6.
Venkateswaran S, Zheng K, Sacchetti M, Gagne D, Arnold DL, Sadovnick AD, Scherer SW,
Banwell B, Bar-Or A, Simon DK; Canadian Pediatric Demyelinating Disease Network
(including Campbell, TL). Mitochondrial DNA haplogroups and mutations in children with
acquired central demyelination. Neurology. 2011 Mar 1;76(9):774-80.
Campbell, T. Multiple Sclerosis: A guide for health care professionals. Multiple Sclerosis
Society of Canada Alberta Division, 2010.

2. Poder, K., Ghatavi, K., Fisk, J.D., Campbell, T.L., Kisley, S., Sarty, I., Stadnyk, K., Bhan, V.,
Social anxiety in a multiple sclerosis clinic population. Multiple Sclerosis 2009; 15; 393-398.
Hebb, A.L.O., Moore, C.S., Bhan, V., Campbell, T., Fisk, J.D., Robertson, H.A., Thorne, M.,
Lacasse, E., Holcik, M., Gillard, J., Crocker, S. J., Robertson, G. S. Expression of the inhibitor of
apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during
autoimmune mediated demyelination. Multiple Sclerosis 2008: 14; 577-594.
Campbell, T. (2007). Highlights from the 20th Annual Meeting of the Consortium of MS
Centers (CMSC), Compass, 8(1), 10-11.
Campbell, T. (2007). Therapies targeting T and B cells, issues in placebo-controlled trails,
neutralizing antibodies, quantifying MS costs….. Highlights from the 20th Annual Meeting of the
Consortium of MS Centers (CMSC), Neurotransmission, 8(1), 9.
Campbell, T. (2007). Highlights from the 20th Annual Meeting of the Consortium of MS
Centers (CMSC), held May 31 to June 3, 2006 in Scottsdale, Arizona. Compass, 8(1), 10-11.
Campbell, T. (2007). Therapies targeting T and B cells, issues in placebo-controlled trails,
neutralizing antibodies, quantifying MS costs….. Highlights from the 20th Annual Meeting of the
Consortium of MS Centers (CMSC), held May 31 to June 3, 2006 in Scottsdale, Arizona.
Neurotransmission, 8(1), 9.
Campbell, T. L. (2004). You’ve just found out that you have multiple sclerosis …now what?
Unrestricted Educational Grant, Biogen Idec Canada Inc
Lanigan, T. L. (2000). The patient family learning centre. The Canadian Nurse, 96(3), 18-22
Lanigan, T. L. (1998). Project Manual Section 1: Stress Management. Prince Edward Island
Hearth Health Program and Healthy Communities in Action Population Health Fund.
Charlottetown, Prince Edward Island, Canada